Both in Biotechnology
Fate Therapeutics vs Alector
Over the past year FATE returned +64.3% and ALEC returned +56.9%; their daily moves had a correlation of 0.28.
FATE +64.3% ALEC +56.9%Growth of $1, one year, split-adjusted
| Metric | FATE | ALEC |
|---|---|---|
| Price | $2.07 | $2.26 |
| Market cap | $248.0M | $252.3M |
| Today | +1.47% | +10.24% |
| 1 month | −9.6% | +24.9% |
| 6 months | −9.6% | −12.1% |
| Year to date | +110.7% | +44.9% |
| 1 year | +64.3% | +56.9% |
| Revenue growth (YoY) | +9.2% | −57.8% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −1448.6% | −692.5% |
| P/E (TTM) | — | — |
| Price / sales | 38.2× | 18.2× |
| Net cash | $153.8M | $162.9M |
| Dividend yield | — | — |
| Volatility (60d) | 56.3% | 85.0% |
| Short % of float | 10.4% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).